I agree that this site is using cookies. You can find further informations here.
X
Hollebecque, A.
400  results:
Search for persons X
?
1

522P Intra-arterial hepatic chemotherapy: Role beyond color..:

El Rawadi, E.J. ; Boileve, A. ; Dall'Olio, F.G....
Annals of Oncology.  35 (2024)  - p. S208 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Pancreatic adenocarcinoma third line systemic treatments: a..:

Gueiderikh, A. ; Tarabay, A. ; Abdelouahab, M....
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

340P Molecular profiling in pancreatic cancers: Therapeutic..:

Tarabay, A. ; Boileve, A. ; Smolenschi, C....
Annals of Oncology.  35 (2024)  - p. S142 , 2024
Link: https://doi.org/10.1016/..
 
?
4

70P Intra-arterial hepatic chemotherapy in metastatic color..:

El Rawadi, E.J. ; Boileve, A. ; Pierotti, L....
Annals of Oncology.  35 (2024)  - p. S34 , 2024
Link: https://doi.org/10.1016/..
 
?
5

234P Do we need molecular profiling in patients with squamo..:

Smolenschi, C. ; Sharaf, R. ; Hollebecque, A....
Annals of Oncology.  35 (2024)  - p. S100-S101 , 2024
Link: https://doi.org/10.1016/..
 
?
6

297P Real-life efficacy of immune checkpoint inhibitors in ..:

Campo le Brun, I. ; Grapinet, E. ; Hollebecque, A....
Annals of Oncology.  35 (2024)  - p. S125 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Codon-specific KRAS mutations predict survival in advanced ..:

Boilève, A. ; Rousseau, A. ; Hilmi, M....
ESMO Gastrointestinal Oncology.  3 (2024)  - p. 100030 , 2024
Link: https://doi.org/10.1016/..
 
?
8

338P Heads or tails? In-depth analysis of pancreatic cancer..:

Fernandes, A. ; Lambert, A. ; Tarabay, A....
Annals of Oncology.  35 (2024)  - p. S142 , 2024
Link: https://doi.org/10.1016/..
 
?
9

An open-label study of pemigatinib in cholangiocarcinoma: f..:

Vogel, A. ; Sahai, V. ; Hollebecque, A....
ESMO Open.  9 (2024)  6 - p. 103488 , 2024
Link: https://doi.org/10.1016/..
 
?
10

291P Tumor biology, treatment patterns, and survival outcom..:

Turpin, A. ; Pudlarz, T. ; Antoun, L....
Annals of Oncology.  35 (2024)  - p. S123 , 2024
Link: https://doi.org/10.1016/..
 
?
11

6O Subcutaneous fat mass predicts progression-free survival..:

Delaye, M. ; Lawrance, L. ; Belkouchi, Y....
ESMO Open.  9 (2024)  - p. 102261 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Infections occurring following IL6 blockade for the managem..:

Valery, M. ; Saleh, K. ; Ecea, R....
Cancer Chemotherapy and Pharmacology.  92 (2023)  3 - p. 229-233 , 2023
Link: https://doi.org/10.1007/..
 
?
13

5O Deciphering resistance mechanisms in cancer: Insights fr..:

Beshiri, K. ; Vasseur, D. ; Bigot, L....
ESMO Open.  8 (2023)  1 - p. 101651 , 2023
Link: https://doi.org/10.1016/..
 
?
14

41P BRCA2 pathogenic variant (PV): A novel agnostic biomark..:

Alonso de Castro, B. ; Gomez Randulfe, M.I. ; Ouali, K....
ESMO Open.  8 (2023)  1 - p. 101007 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Efficacy of immunotherapy in mismatch repair-deficient adva..:

Alouani, E. ; Mercier, M. ; Flecchia, C....
ESMO Open.  8 (2023)  3 - p. 101574 , 2023
Link: https://doi.org/10.1016/..
 
1-15